Due to the lower frequency of PTCL development in Dnmt3a-deficient mice, larger cohorts of mice will need to be analyzed to determine whether Dnmt3a tumor suppressor function in prevention of PTCL is also autonomous to hematopoietic system. The gene discussed is DNMT3A; the disease is neoplasm.